KRAS and colorectal carcinoma: Neither the loss of MMR proteins nor pathogenic variants of KRAS, NRAS and BRAF, which are molecular lesions usually associated with hereditary or familial EO-CRC [20], were revealed in the neoplastic colon tissue.